Antoine Mahé, Author at Biowebspin | Biowebspin
Logo Biowebspin

Antoine Mahé, Author at Biowebspin's Posts

Event Listing: BioFIT 2017 – November 28th – 29th / Strasbourg, FR – 6th edition

From November 26th to November 29th, the 6th Biofit edition will be held in Strasbourg. With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public res... »

Event Listing: 18th Annual Drug Discovery Summit, 12-13 June 2017, Berlin

Event Listing: 18th Annual Drug Discovery Summit, 12-13 June 2017, Berlin

  Oxford Global’s - 18th Annual Drug Discovery Leaders’ Summit 12-13 June 2017, Hotel Palace in Berlin, Germany. Oxford Global present the 18th Annual Drug Discovery Leaders’ Summit that brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective e... »

Didier Hoch is speaking about the Biovision Forum, 13 – 14 April 2016 at Lyon, France

Didier Hoch is speaking about the Biovision Forum, 13 – 14 April 2016 at Lyon, France

Didier Hoch is speaking about the Biovision Forum, 13 - 14 April 2016 at Lyon, France. About Didier Hoch: -Chairman at Biovision -Director of Big Booster -Board member of DBV Technologies, Effimune, Genticel   »

Kristof-van-Emelen

Kristof van Emelen is speaking about open innovation at Janssen

Kristof van Emelen is  speaking about open innovation at Janssen. About Kristof van Emelen: -Director Emerging Sciences and Innovation at Janssen Pharmaceutical -Contributed to the discovery of R306465, a novel inhibitor of class I histone deacetylases with broad-spectrum anti-tumoral activity -2007/2011: Director of Medicinal Chemistry at Tibotec -Ph.D. degree in organic chemistry See Biowebspin'... »

Kamal-Azzaoui

Kamal Azzaoui, Novartis, about “Scientific competency questions as the basis for semantically enriched open pharmacological space development”

Kamal Azzaoui is speaking about the main message of his publication ‘Scientific competency questions as the basis for semantically enriched open pharmacological space development’ (see also the abstract below). He explains why collaboration between academia and industry is important and finally gives advices.   Scientific competency questions as the basis for semantically enriched open pharma... »

David Andrews, Astrazeneca, about: “Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface”

David Andrews, Astrazeneca, about: “Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface”

David Andrews is speaking about the main message of his publication ‘Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface’ (see also the abstract below). He explains why collaboration between academia and industry is important and finally gives advices. Collaborative practices for medicinal chemistry research across the big pharma and not-for-... »

Azzurra Morreale, University of Palermo, about: “Open innovation: A real option to restore value to the biopharmaceutical R&D”

Azzurra Morreale, University of Palermo, about: “Open innovation: A real option to restore value to the biopharmaceutical R&D”

Azzurra Morreale is speaking about the main message of her publication ‘Open innovation: A real option to restore value to the biopharmaceutical R&D’ (see also the abstract below). She explains why collaboration between academia and industry is important and finally gives advices. Open innovation: A real option to restore value to the biopharmaceutical R&D by Giovanna Lo Nigro, Azzurra Mor... »

Elicia Maine, Beedie School of Business, about “The role of entrepreneurial decision-making in opportunity creation and recognition”

Elicia Maine, Beedie School of Business, about “The role of entrepreneurial decision-making in opportunity creation and recognition”

Elicia Maine is speaking about the main message of her publication ‘The role of entrepreneurial decision-making in opportunity creation and recognition’ (see also the abstract below). She explains why collaboration between academia and industry is important and finally gives advices.   The role of entrepreneurial decision-making in opportunity creation and recognition by Elicia Maine, Pek-Hoo... »

Stephen Roper, Enterprise Research Centre and Warwick Business School, about “Knowledge stocks, knowledge flows and innovation: Evidence from matched patents and innovation panel data”

Stephen Roper, Enterprise Research Centre and Warwick Business School, about “Knowledge stocks, knowledge flows and innovation: Evidence from matched patents and innovation panel data”

Stephen Roper, is speaking about the main message of his publication ‘Knowledge stocks, knowledge flows and innovation: Evidence from matched patents and innovation panel data’ (see also the abstract below). He explains why collaboration between academia and industry is important and finally gives advices. Knowledge stocks, knowledge flows and innovation: Evidence from matched patents and innovati... »

Giovanni-Perrone

Giovanni Perrone & Erica Mazzola, University of Palermo, about “Network embeddedness and new product development in the biopharmaceutical industry: The moderating role of open innovation flow”

Giovanni Perrone and Erica Mazzola are speaking about the main message of their publication ‘Network embeddedness and new product development in the biopharmaceutical industry: The moderating role of open innovation flow’ (see also the abstract below). They explain why collaboration between academia and industry is important and finally give advices. Network embeddedness and new product developmen... »

Page 1 of 212